Saffron in the treatment of patients with mild to moderate Alzheimer’s disease: a 16-week, randomized and placebo-controlled trial.
What is known: Herbal medicines have been used in the treatment of behavioural and psychological symptoms of dementia but with variable response. Crocus sativus (saffron) may inhibit the aggregation and deposition of amyloid β in the human brain and may therefore be useful in Alzheimer’s disease (AD...
| Published in: | Journal of Clinical Pharmacy & Therapeutics Vol. 35; no. 5; pp. 581 - 589 |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | clinical trial research tables/charts Journal Article |
| Published: |
Wiley-Blackwell
Oct2010
|
| Online Access: | View this record in EBSCOhost |